NASDAQ: RVMD
Revolution Medicines Inc Stock Forecast, Predictions & Price Target

Analyst price target for RVMD

Based on 19 analysts offering 12 month price targets for Revolution Medicines Inc

Min Forecast
$179.00+10.03%
Avg Forecast
$265.68+63.31%
Max Forecast
$350.00+115.13%

Should I buy or sell RVMD stock?

Based on 20 analysts offering ratings for Revolution Medicines Inc.

Strong Buy
Strong Buy
11 analysts 55%
Buy
8 analysts 40%
Hold
1 analysts 5%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although RVMD's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates RVMD as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their RVMD stock forecasts and price targets.

RVMD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-11-17
lockedlocked$00.00+00.00%2026-11-13
lockedlocked$00.00+00.00%2026-11-05
lockedlocked$00.00+00.00%2026-11-05
lockedlocked$00.00+00.00%2026-11-05Find Out Why
Truist Securities
Top 2%
99
Strong BuyReiterates$261.00+60.43%2026-11-05
Guggenheim
Top 16%
85
Strong BuyMaintains$298.00+83.17%2026-11-05
Evercore ISI Group
Top 18%
83
BuyMaintains$340.00+108.99%2026-11-05
William Blair
Top 5%
96
BuyInitiates Coverage OnN/AN/A2026-10-16
Needham
Top 1%
100
BuyReiterates$275.00+69.03%2026-10-15

1 of 2

Forecast return on equity

Is RVMD forecast to generate an efficient return?

Company
27.68%
Industry
43.27%
Market
164.09%
RVMD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RVMD forecast to generate an efficient return on assets?

Company
15.45%
Industry
21.27%
RVMD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RVMD earnings per share forecast

What is RVMD's earnings per share in the next 3 years based on estimates from 28 analysts?

Avg 1 year Forecast
-$9.71
Avg 2 year Forecast
-$5.78
Avg 3 year Forecast
-$1.98

RVMD revenue forecast

What is RVMD's revenue in the next 3 years based on estimates from 27 analysts?

Avg 1 year Forecast
$262.8M+33.01%
Avg 2 year Forecast
$1.4B+611.69%
Avg 3 year Forecast
$2.9B+1,356.27%
RVMD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RVMD revenue growth forecast

How is RVMD forecast to perform vs Biotechnology companies and vs the US market?

Company
142.34%
Industry
31.63%
Market
12.01%
RVMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RVMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RVMD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RVMD$162.69$265.68+63.31%Strong Buy
GMAB$51.96$61.67+18.68%Strong Buy
RPRX$68.68$68.00-0.99%Strong Buy
ROIV$38.71$51.67+33.47%Strong Buy
INSM$121.86$195.62+60.52%Strong Buy

Revolution Medicines Stock Forecast FAQ

Is Revolution Medicines Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 20 Wall Street analysts covering (NASDAQ: RVMD) stock is to Strong Buy RVMD stock.

Out of 20 analysts, 11 (55%) are recommending RVMD as a Strong Buy, 8 (40%) are recommending RVMD as a Buy, 1 (5%) are recommending RVMD as a Hold, 0 (0%) are recommending RVMD as a Sell, and 0 (0%) are recommending RVMD as a Strong Sell.

If you're new to stock investing, here's how to buy Revolution Medicines stock.

What is RVMD's earnings growth forecast for 2026-2028?

(NASDAQ: RVMD) Revolution Medicines's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.17%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33%.

Revolution Medicines's earnings in 2026 is -$1,870,536,000.On average, 28 Wall Street analysts forecast RVMD's earnings for 2026 to be -$2,099,917,276, with the lowest RVMD earnings forecast at -$2,579,632,019, and the highest RVMD earnings forecast at -$1,771,434,125. On average, 27 Wall Street analysts forecast RVMD's earnings for 2027 to be -$1,249,780,301, with the lowest RVMD earnings forecast at -$1,873,783,653, and the highest RVMD earnings forecast at -$299,781,160.

In 2028, RVMD is forecast to generate -$427,588,293 in earnings, with the lowest earnings forecast at -$2,159,938,396 and the highest earnings forecast at $1,212,751,055.

What is RVMD's revenue growth forecast for 2026-2028?

(NASDAQ: RVMD) Revolution Medicines's forecast annual revenue growth rate of 142.34% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 31.63%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.01%.

Revolution Medicines's revenue in 2026 is $197,559,000.On average, 27 Wall Street analysts forecast RVMD's revenue for 2026 to be $56,837,296,638, with the lowest RVMD revenue forecast at $10,911,947,695, and the highest RVMD revenue forecast at $159,145,728,340. On average, 26 Wall Street analysts forecast RVMD's revenue for 2027 to be $304,107,006,138, with the lowest RVMD revenue forecast at $63,589,942,962, and the highest RVMD revenue forecast at $766,323,700,389.

In 2028, RVMD is forecast to generate $622,273,013,271 in revenue, with the lowest revenue forecast at $275,556,419,502 and the highest revenue forecast at $1,015,925,041,131.

What is RVMD's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: RVMD) forecast ROA is 15.45%, which is lower than the forecast US Biotechnology industry average of 21.27%.

What is RVMD's Price Target?

According to 19 Wall Street analysts that have issued a 1 year RVMD price target, the average RVMD price target is $265.68, with the highest RVMD stock price forecast at $350.00 and the lowest RVMD stock price forecast at $179.00.

On average, Wall Street analysts predict that Revolution Medicines's share price could reach $265.68 by Nov 17, 2027. The average Revolution Medicines stock price prediction forecasts a potential upside of 63.31% from the current RVMD share price of $162.69.

What is RVMD's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: RVMD) Revolution Medicines's current Earnings Per Share (EPS) is -$9.14. On average, analysts forecast that RVMD's EPS will be -$9.71 for 2026, with the lowest EPS forecast at -$11.93, and the highest EPS forecast at -$8.19. On average, analysts forecast that RVMD's EPS will be -$5.78 for 2027, with the lowest EPS forecast at -$8.66, and the highest EPS forecast at -$1.39. In 2028, RVMD's EPS is forecast to hit -$1.98 (min: -$9.99, max: $5.61).

What is RVMD's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: RVMD) forecast ROE is 27.68%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.